Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Irritable Bowel Syndrome

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 64 articles: HTML format

Single Articles

November 2025
1. SHIN A, Staller K, Levinthal DJ
   Actionable Clinical Features and Biomarkers to Facilitate the Management of Irritable Bowel Syndrome.
   Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003859.
   PubMed     Abstract available
   
   
   
2. ALGERA JP, Melchior C, Colomier E, Tornblom H, et al
   Hypersensitivity to the lactulose nutrient challenge test in irritable bowel syndrome - a non-invasive test of meal-related symptoms.
   Am J Gastroenterol. 2025 Nov 17. doi: 10.14309/ajg.0000000000003843.
   PubMed     Abstract available
   
   
   September 2025
3. TORNKVIST N, Palsson OS, Hreinsson J, Sperber AD, et al
   Global prevalence, characterization and impact of Functional Bowel Disorders.
   Am J Gastroenterol. 2025 Sep 29. doi: 10.14309/ajg.0000000000003782.
   PubMed     Abstract available
   
   
   June 2025
4. RAO SSC
   Fructose and Lactose Malabsorption or Intolerance or Hypersensitivity: Which Triggers Symptoms and Why?
   Am J Gastroenterol. 2025 Jun 26. doi: 10.14309/ajg.0000000000003577.
   PubMed    
   
   
   
5. AWAD DC, Hubner DM
   The impact of violence and trauma on patient care: What the gastroenterologist needs to know.
   Am J Gastroenterol. 2025 Jun 10. doi: 10.14309/ajg.0000000000003587.
   PubMed    
   
   
   
6. SHIHA MG, Schiepatti A, Manza F, Maimaris S, et al
   Global prevalence of celiac disease in patients with Rome III and Rome IV irritable bowel syndrome: A systematic review and meta-analysis.
   Am J Gastroenterol. 2025 Jun 10. doi: 10.14309/ajg.0000000000003586.
   PubMed     Abstract available
   
   
   
7. KARRENTO K, Lu PL, Chumpitazi BP
   Little Patients Big Discoveries: Potential Pediatric to Adult Neurogastroenterology Translation.
   Am J Gastroenterol. 2025 Jun 6. doi: 10.14309/ajg.0000000000003579.
   PubMed     Abstract available
   
   
   
8. BUSAM JA, Batta N, Shah ED, Joo L, et al
   The Safety of Pharmacotherapy for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis.
   Am J Gastroenterol. 2025 Jun 5. doi: 10.14309/ajg.0000000000003572.
   PubMed     Abstract available
   
   
   May 2025
9. CALDART F, Gabriel C, Vauquelin B, Riviere P, et al
   Overlap of esophageal disorders of gut-brain interactions (E-DGBIs) and GERD is highly prevalent in patients with refractory reflux symptoms.
   Am J Gastroenterol. 2025 May 22. doi: 10.14309/ajg.0000000000003542.
   PubMed     Abstract available
   
   
   
10. THERRIEN A, Akula S, Galeas-Pena M, Frank E, et al
    Hereditary Alpha-Tryptasemia is Associated with Ongoing Symptoms in Individuals with Celiac Disease Despite Following a Gluten-Free Diet.
    Am J Gastroenterol. 2025 May 14. doi: 10.14309/ajg.0000000000003537.
    PubMed     Abstract available
    
    
    
11. DUGGAL S, Mahapatra S, Garrison K, Robles A, et al
    Assessing Gastrointestinal Awareness on TikTok: A Content Analysis of Colorectal Cancer, IBS, and IBD Narratives.
    Am J Gastroenterol. 2025 May 14. doi: 10.14309/ajg.0000000000003539.
    PubMed     Abstract available
    
    
    
12. SAAB O, Al-Obaidi H, Algodi M, Algodi A, et al
    Yoga for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2025 May 13. doi: 10.14309/ajg.0000000000003524.
    PubMed     Abstract available
    
    
    
13. LI D, Yang J
    Methodological Challenges and Suggestions for Improvement in the Study of Irritable Bowel Syndrome Flora.
    Am J Gastroenterol. 2025 May 2. doi: 10.14309/ajg.0000000000003489.
    PubMed    
    
    
    April 2025
14. WEI J, Zhong Y, Li Y, Li J, et al
    Addressing Mechanistic and Subtype-specific Limitations in the Study on Fecal Proteolytic Bacteria and Staphylococcal Superantigens in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2025 Apr 28. doi: 10.14309/ajg.0000000000003453.
    PubMed    
    
    
    
15. CAMILLERI M
    When and What to Test for Diarrhea: Focus on Stool Testing.
    Am J Gastroenterol. 2025;120:778-784.
    PubMed     Abstract available
    
    
    
16. WALLEN H, Ljotsson B, Lindfors P, Forsell E, et al
    Internet-Delivered Exposure-Based Cognitive Behavior Therapy for Irritable Bowel Syndrome: A Clinical Effectiveness Study.
    Am J Gastroenterol. 2025;120:856-863.
    PubMed     Abstract available
    
    
    December 2024
17. PARK CJ, Jones MP, Prott G, Sequeira C, et al
    Rome IV Functional Defecation Disorder: Time for a Change in Symptom Criteria for Improved Clinical Relevance?
    Am J Gastroenterol. 2024;120:2165-2172.
    PubMed     Abstract available
    
    
    
18. LIU J, Lv C, Yin M, Zhu M, et al
    Efficacy and safety of transcutaneous auricular vagus nerve stimulation in patients with constipation-predominant irritable bowel syndrome: a single-center, single-blind, randomized controlled trial.
    Am J Gastroenterol. 2024 Dec 17. doi: 10.14309/ajg.0000000000003257.
    PubMed     Abstract available
    
    
    November 2024
19. NYBACKA S, Colomier E, Hreinsson JP, Storsrud S, et al
    Dietary intake and quality in irritable bowel syndrome: a comparative study with controls and the association with symptom severity.
    Am J Gastroenterol. 2024 Nov 27. doi: 10.14309/ajg.0000000000003249.
    PubMed     Abstract available
    
    
    
20. BALSIGER LM, Santos J, Serra J, Piessevaux H, et al
    A Phase II, multicentric, randomized, double-blind, placebo controlled, proof of concept study of efficacy and safety of Rifamycin SV-MMX(R) 600 mg tablets administered three or two times daily to patients with diarrhea-predominant irritable bowel syn
    Am J Gastroenterol. 2024 Nov 26. doi: 10.14309/ajg.0000000000003236.
    PubMed     Abstract available
    
    
    September 2024
21. KERBAGE A, Loesch J, Hamza E, Khan S, et al
    Evaluating Equity in Clinical Trial Accessibility: An Analysis of Demographic, Socioeconomic, and Educational Disparities in IBS Drug Trials.
    Am J Gastroenterol. 2024 Sep 24. doi: 10.14309/ajg.0000000000003099.
    PubMed     Abstract available
    
    
    
22. BOSMAN M, Vork L, Jonkers D, Snijkers J, et al
    Results from a psychometric validation study: irritable bowel syndrome patients report higher symptom burden using end-of-day versus real-time assessment.
    Am J Gastroenterol. 2024 Sep 23. doi: 10.14309/ajg.0000000000003091.
    PubMed     Abstract available
    
    
    
23. JONES MP, Koloski NA, Walker MM, Holtmann GJ, et al
    A Minority of Childhood Disorders of Gut-Brain Interaction Persist Into Adulthood: A Risk-Factor Analysis.
    Am J Gastroenterol. 2024;119:1894-1900.
    PubMed     Abstract available
    
    
    August 2024
24. QUAN R, Decraecker L, Appeltans I, Cuende-Estevez M, et al
    Fecal Proteolytic Bacteria and Staphylococcal Superantigens are Associated with Abdominal Pain Severity in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2024 Aug 21. doi: 10.14309/ajg.0000000000003042.
    PubMed     Abstract available
    
    
    July 2024
25. 
    Correction to: The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation.
    Am J Gastroenterol. 2024;119:1442-1444.
    PubMed    
    
    
    June 2024
26. ANDERSON EJ, Peters SL, Gibson PR, Halmos EP, et al
    Comparison of digitally-delivered gut-directed hypnotherapy program to an active control for irritable bowel syndrome.
    Am J Gastroenterol. 2024 Jun 28. doi: 10.14309/ajg.0000000000002921.
    PubMed     Abstract available
    
    
    May 2024
27. TUNALI V, Arslan NC, Ermis BH, Hakim GD, et al
    A Multicenter Randomized Controlled Trial Of Microbiome-Based Artificial Intelligence-Assisted Personalized Diet Vs Low Fodmap Diet: A Novel Approach for the Management of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2024 May 8. doi: 10.14309/ajg.0000000000002862.
    PubMed     Abstract available
    
    
    April 2024
28. HANNA-JAIRALA I, Drossman DA
    CENTRAL NEUROMODULATORS IN IRRITABLE BOWEL SYNDROME. WHY, HOW AND WHEN.
    Am J Gastroenterol. 2024 Apr 9. doi: 10.14309/ajg.0000000000002800.
    PubMed     Abstract available
    
    
    March 2024
29. CASH BD
    Congratulations. You Have Irritable Bowel Syndrome.
    Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002734.
    PubMed    
    
    
    
30. SHIN A, Xu H
    Healthcare Costs of Irritable Bowel Syndrome (IBS) and IBS Subtypes in the United States.
    Am J Gastroenterol. 2024 Mar 14. doi: 10.14309/ajg.0000000000002753.
    PubMed     Abstract available
    
    
    January 2024
31. LEMBO AJ, Chey WD, Harris LA, Frazier R, et al
    Abdominal Symptom Improvement During Clinical Trials of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation: A Post Hoc Analysis.
    Am J Gastroenterol. 2024 Jan 31. doi: 10.14309/ajg.0000000000002685.
    PubMed     Abstract available
    
    
    
32. LI F, Yano Y, Etievant L, Daniel CR, et al
    The Time-Dependent Association between Irritable Bowel Syndrome and All-cause and Cause-specific Mortality: A Prospective Cohort Study within the UK Biobank.
    Am J Gastroenterol. 2024 Jan 26. doi: 10.14309/ajg.0000000000002675.
    PubMed     Abstract available
    
    
    
33. VAN TILBURG MAL, Rana H
    Well-Being of Patients With Irritable Bowel Syndrome: A Shift From Measuring Deficits to Strengths?
    Am J Gastroenterol. 2024 Jan 2. doi: 10.14309/ajg.0000000000002601.
    PubMed    
    
    
    
34. 
    American College of Gastroenterology Monograph on Microbiome Therapeutics.
    Am J Gastroenterol. 2024;119.
    PubMed    
    
    
    October 2023
35. SNIJKERS JTW, Winkens B, Weerts ZZRM, Vork L, et al
    Satisfaction with life in IBS is associated with psychological burden rather than gastrointestinal symptom severity.
    Am J Gastroenterol. 2023 Oct 4. doi: 10.14309/ajg.0000000000002547.
    PubMed     Abstract available
    
    
    September 2023
36. TOPAN R, Vork L, Fitzke BSocSci H, Pandya S, et al
    Poor subjective sleep quality predicts symptoms in Irritable Bowel Syndrome using the Experience Sampling Method.
    Am J Gastroenterol. 2023 Sep 22. doi: 10.14309/ajg.0000000000002510.
    PubMed     Abstract available
    
    
    May 2023
37. KHAN Z
    Continuing Medical Education Questions: May 2023.
    Am J Gastroenterol. 2023;118:779.
    PubMed     Abstract available
    
    
    April 2023
38. BALLOU S, Rangan V, Eidelberg A, Proctor S, et al
    What is unspecified functional bowel disorder? A commonly seen, rarely recognized, and poorly understood diagnosis.
    Am J Gastroenterol. 2023 Apr 13. doi: 10.14309/ajg.0000000000002281.
    PubMed     Abstract available
    
    
    
39. YANG PL, Kamp KJ, Burr RL, Tang HJ, et al
    Age Differences in Core Symptoms and Symptom Relationships in Patients with Irritable Bowel Syndrome: A Network Analysis.
    Am J Gastroenterol. 2023 Apr 11. doi: 10.14309/ajg.0000000000002280.
    PubMed     Abstract available
    
    
    February 2023
40. SALEH ZM, Chey WD, Berry S
    Behavioral Health Digital Therapeutics for Patients with Irritable Bowel Syndrome: A Primer for Gastroenterologists.
    Am J Gastroenterol. 2023 Feb 16. doi: 10.14309/ajg.0000000000002220.
    PubMed    
    
    
    January 2023
41. DAMIANOS JA, Tomar SK, Azpiroz F, Barba E, et al
    Abdominophrenic Dyssynergia: A Narrative Review.
    Am J Gastroenterol. 2023;118:41-45.
    PubMed     Abstract available
    
    
    December 2022
42. BAI T, Xu Z, Xia P, Feng Y, et al
    The Short-term Efficacy of Bifidobacterium Quadruple Viable Tablet in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: Potentially Mediated by Metabolism rather than Diversity Regulation.
    Am J Gastroenterol. 2022 Dec 23. doi: 10.14309/ajg.0000000000002147.
    PubMed     Abstract available
    
    
    
43. GEARRY R, Fukudo S, Barbara G, Kuhn-Sherlock B, et al
    Consumption of two green kiwifruit daily improves constipation and abdominal comfort - results of an international multicentre randomised controlled trial.
    Am J Gastroenterol. 2022 Dec 20. doi: 10.14309/ajg.0000000000002124.
    PubMed     Abstract available
    
    
    
44. JONES MP, Guthrie-Lyons L, Sato YA, Talley NJ, et al
    Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials.
    Am J Gastroenterol. 2022 Dec 20. doi: 10.14309/ajg.0000000000002097.
    PubMed     Abstract available
    
    
    
45. SPIEGEL B
    Gravity and the Gut: A Hypothesis of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2022;117:1933-1947.
    PubMed     Abstract available
    
    
    November 2022
46. D'SILVA A, Marshall DA, Vallance JK, Nasser Y, et al
    Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial.
    Am J Gastroenterol. 2022 Nov 25. doi: 10.14309/ajg.0000000000002052.
    PubMed     Abstract available
    
    
    October 2022
47. BRENNER DM, Lacy BE, Ford AC, Bartolini W, et al
    Linaclotide Reduced Response Time for Irritable Bowel Syndrome with Constipation Symptoms: Analysis of Four Randomized Controlled Trials.
    Am J Gastroenterol. 2022 Oct 12. pii: 00000434-990000000-00551.
    PubMed     Abstract available
    
    
    September 2022
48. VILLANUEVA-MILLAN MJ, Leite G, Wang J, Morales W, et al
    Methanogens and Hydrogen Sulfide Producing Bacteria Guide Distinct Gut Microbe Profiles and Irritable Bowel Syndrome Subtypes.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00500.
    PubMed     Abstract available
    
    
    August 2022
49. NORDIN E, Hellstrom PM, Brunius C, Landberg R, et al
    Modest conformity between self-reporting of Bristol stool form and fecal consistency measured by stool water content in irritable bowel syndrome, a FODMAP and gluten trial.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00449.
    PubMed     Abstract available
    
    
    July 2022
50. VOLLEBREGT PF, Wiklendt L, Burgell RE, Chaichanavichkij P, et al
    Abnormal Perception of Urge to Defecate: An Important Pathophysiological Mechanism in Women With Chronic Constipation.
    Am J Gastroenterol. 2022;117:1125-1136.
    PubMed     Abstract available
    
    
    June 2022
51. HUANG Z, Lin Z, Lin C, Chu H, et al
    Transcutaneous Electrical Acustimulation Improves Irritable Bowel Syndrome with Constipation by Accelerating Colon Transit and Reducing Rectal Sensation via Autonomic Mechanisms.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00418.
    PubMed     Abstract available
    
    
    
52. TACK J, Tornblom H, Tan V, Carbone F, et al
    Evidence-Based and Emerging Dietary Approaches to Upper Disorders of Gut-Brain Interaction.
    Am J Gastroenterol. 2022;117:965-972.
    PubMed     Abstract available
    
    
    May 2022
53. VAN DEN HOUTE K, Bercik P, Simren M, Tack J, et al
    Mechanisms underlying food-triggered symptoms in disorders of gut-brain interactions.
    Am J Gastroenterol. 2022 May 4. pii: 00000434-990000000-00357.
    PubMed     Abstract available
    
    
    
54. DULANEY DT
    Continuing Medical Education Questions: May 2022.
    Am J Gastroenterol. 2022;117:720.
    PubMed     Abstract available
    
    
    
55. LACY BE, Cangemi DJ
    A Pragmatic Approach to the Evaluation and Treatment of Abdominal Bloating.
    Am J Gastroenterol. 2022;117:701-705.
    PubMed    
    
    
    April 2022
56. ZHANG X, Xiao X, Yang JL
    Shall we reduce endoscopy in patients with irritable bowel syndrome?
    Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00342.
    PubMed    
    
    
    
57. SINGH P, Tuck C, Gibson PR, Chey WD, et al
    The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation.
    Am J Gastroenterol. 2022 Apr 8. pii: 00000434-990000000-00347.
    PubMed     Abstract available
    
    
    
58. BRENNER DM, Harris LA, Chang CH, Waldman SA, et al
    Real-World Treatment Strategies to Improve Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed     Abstract available
    
    
    
59. KASSEBAUM-LADEWSKI A, Poppers DM, Brenner DM
    Effective Communication Strategies and Tools for Improving Treatment Outcomes in Patients With Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed     Abstract available
    
    
    
60. SAYUK GS, Waldman SA, Brenner DM
    Mechanisms of Action of Current Pharmacologic Options for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation.
    Am J Gastroenterol. 2022;117.
    PubMed     Abstract available
    
    
    
61. HARRIS LA, Chang CH
    Burden of Constipation: Looking Beyond Bowel Movements.
    Am J Gastroenterol. 2022;117.
    PubMed     Abstract available
    
    
    
62. BRENNER DM
    Best Practices for the Management of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation: A Roundtable Discussion and Review.
    Am J Gastroenterol. 2022;117.
    PubMed    
    
    
    March 2022
63. PIMENTEL M, Mathur R, Wang J, Chang C, et al
    A Smartphone Application Using Artificial Intelligence Is Superior to Subject Self-Reporting When Assessing Stool Form.
    Am J Gastroenterol. 2022 Mar 14. pii: 00000434-990000000-00275.
    PubMed     Abstract available
    
    
    
64. TAKAKURA W, Pimentel M, Rao S, Villanueva-Millan MJ, et al
    A Single Fasting Exhaled Methane Level Correlates With Fecal Methanogen Load, Clinical Symptoms and Accurately Detects Intestinal Methanogen Overgrowth.
    Am J Gastroenterol. 2022;117:470-477.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge.